NPF-GRAPPA Dermatology-Rheumatology Collaborative Initiative - Boston

Boston, MA US
April 30, 2016

NPF and GRAPPA will provide live, local education for rheumatologists, dermatologists, primary care providers and allied health in 5 regional conferences planned for 2016.   Each conference will feature nationally recognized experts, chosen from the members of each organization. Attendees will receive a maximum of 4.75 AMA PRA Category 1 CreditsTM through didactic lectures, case-based presentations, and breakout sessions demonstrating physical exams and ultrasound techniques on patients.   During the sessions, questions will be asked using an electronic audience response system, and learner participation will be encouraged throughout the sessions, especially during the hands-on portion of the physical exam and the Ask an Expert session. The session will also feature a patient speaker who will inform the audience about quality of life considerations with psoriatic disease. 

This activity is supported by educational grants from AbbVie, Celgene Corporation, Janssen Biotech, Mallinckrodt Pharmaceuticals and Pfizer.


If you do not yet have an account with the National Psoriasis Foundation, please click here to create a new account prior to registering for this course. Thank you!

Target Audience

Dermatologists, Rheumatologists, Allied Health Care Providers

Learning Objectives

After completing this activity, participants should be able to:

• Discuss the epidemiology, clinical features, and classification of psoriasis and psoriatic arthritis (PsA)

• Describe current understanding of the pathogenesis of psoriasis and PsA

• Implement most recent methods to assess and treat psoriasis and PsA

• Identify and better manage key co-morbidities of psoriasis and psoriatic arthritis and their impact

Additional Information

Program Agenda153.99 KB
Course summary
Available credit: 
  • 4.75 AMA PRA Category 1 Credit™


    This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint providership of Oregon Health & Science University (OHSU) and the National Psoriasis Foundation. OHSU is accredited by the ACCME to provide CME for physicians.


    OHSU School of Medicine, Division of CME, designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
Course expires: 
Event starts: 
04/30/2016 - 8:00am
Event ends: 
04/30/2016 - 2:00pm
The Westin Boston Waterfront
425 Summer St
Boston, MA 02210
United States

Program Chairs

Philip Mease, M.D.
Director, Rheumatology Research
Swedish Medical Center
Clinical Professor
University of Washington School of Medicine
Seattle, Washington


Amit Garg, M.D.
Chair of Dermatology
Hofstra North Shore-LIJ School of Medicine
Manhasset, New York

Session Faculty

Amit Garg, M.D.
Chair of Dermatology
Hofstra North Shore-LIJ School of Medicine
Manhasset, New York

Christopher Ritchlin, M.D.
Chief, Department of Medicine, Allergy/Immunology and Rheumatology
University of Rochester Medical Center
Rochester, New York

Alice Gottlieb, M.D., Ph.D.
Harvey B. Ansell Professor of Dermatology
Tufts University School of Medicine
Boston, Massachusetts

Joseph Merola, M.D., M.M.S.C.
Harvard Medical School
Director of Clinical Trials
Assistant Program Director, Combined Internal Medicine-Dermatology Residency Training Program
Co-Director, Center for Skin and Related Musculoskeletal Diseases

Brigham and Women's Hospital
Boston, Massachusetts

Accreditation Period

Course opens: 
Course expires: 


Please login to take this course.